Authors
Alessandro Busca, Jon Salmanton-García, Paolo Corradini, Francesco Marchesi, Alba Cabirta, Roberta Di Blasi, Remy Dulery, Sylvain Lamure, Francesca Farina, Barbora Weinbergerová, Josip Batinić, Anna Nordlander, Alberto López-García, Ľuboš Drgoňa, Ildefonso Espigado-Tocino, Iker Falces-Romero, Ramón García-Sanz, Carolina García-Vidal, Anna Guidetti, Nina Khanna, Austin Kulasekararaj, Johan Maertens, Martin Hoenigl, Nikolai Klimko, Philipp Koehler, Antonio Pagliuca, Francesco Passamonti, Oliver A Cornely, Livio Pagano
Publication date
2022/4/12
Journal
Blood advances
Volume
6
Issue
7
Pages
2427-2433
Publisher
American Society of Hematology
Description
Key Points
- The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy.
- Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.
Total citations
Scholar articles
A Busca, J Salmanton-García, P Corradini, F Marchesi… - Blood advances, 2022
R Dulery, S Lamure, F Farina, B Weinbergerová… - 2022